Search Results 681-690 of 16015 for pharmacogenetics
The purpose of this study is to create a repository for cerebellar ataxia and nucleotide repeat diseases in order to fully investigate the genetic and ...
Review focus areas, mentors and publications of current and former trainees in the Endocrinology, Diabetes and Metabolism Training Program at Mayo Clinic.
The purpose of this study is to collect medical and personal histories, blood and/or tumor tissue samples from patients who are long-term survivors of lung ...
Hear lively discussions between a Mayo Clinic colleague and guests from external institutions on population genomics, individualized vaccines, genome editing ...
This partially randomized phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
About this study. The purpose of this study is to assess age-dependent increases in Von Willebrand Factor (VWF) levels in patients with Type 1 Von ...
The purpose of this study is to use a patient's own cells to fabricate a recellularized scaffold to repopulate the lung and restore function that could offer a ...
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
August John, Ph.D. student at Mayo Clinic Graduate School of Biomedical Sciences, shares research on developing a new method to optimize cancer drugs.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.